Lv3
310 积分 2025-02-14 加入
Patisiran: First Global Approval
1天前
已完结
Patisiran: First Global Approval
1天前
已完结
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
1天前
已完结
In vitro and in vivo evaluation of clinically-approved ionizable cationic lipids shows divergent results between mRNA transfection and vaccine efficacy
6天前
已完结
Efficient and safe in vivo treatment of primary hyperoxaluria type 1 via LNP-CRISPR-Cas9-mediated glycolate oxidase disruption
11天前
已完结
Targeting Ligand Independent Tropism of siRNA‐LNP by Small Molecules for Directed Therapy of Liver or Myeloid Immune Cells
11天前
已完结
A combinatorial siRNA and mRNA approach for obesity treatment using targeting lipid nanoparticles
11天前
已完结
Lipid nanoparticle-based strategies for extrahepatic delivery of nucleic acid therapies – challenges and opportunities
11天前
已完结
In Vivo mRNA CAR T Cell Engineering via Targeted Ionizable Lipid Nanoparticles with Extrahepatic Tropism
11天前
已完结
Targeted siRNA lipid nanoparticles for the treatment of KRAS-mutant tumors
15天前
已完结
皖公网安备34019202002308
